Spain is set to launch its largest-ever oncology research funding initiative in 2026, spearheaded by the Spanish Association for cancer Research and its Scientific Foundation. The over 40 million euro investment aims to bolster a field often constrained by funding and specialized expertise,and builds upon the association’s existing commitment to supporting over 2,300 researchers [[1]]. this effort reflects a growing national focus on improving cancer survival rates – currently, one in two men and one in three women in Spain will face a cancer diagnosis in their lifetime – and a paradigm shift toward preventative strategies [[2]],[[3]].
Cancer research is making increasing strides, though progress is often hampered by challenges like limited funding and a shortage of specialized experts. Now, the Spanish Association for Cancer Research (Asociación Española Contra el Cáncer) is poised to launch what will be the largest funding initiative for oncology research in Spain in 2026, through its Scientific Foundation.
The investment, exceeding 40 million euros – surpassing this year’s allocation – will support projects covering all stages of the disease, with a particular focus on cancers with low survival rates, preventative measures, and innovative approaches. This commitment solidifies the Association’s position as the leading funder of cancer research in the country, currently supporting a network of 2,300 researchers and over 750 active projects. This increased funding is crucial as cancer remains a significant global health concern.
Dr. Marta Puyol, Scientific Director of the Spanish Association for Cancer Research’s Scientific Foundation, explains the goal of these grants is to “prevent cancer before it ignites.” She describes this as an “innovative approach” that aims not only to cure the disease, but to anticipate, identify, and block the changes in cells and DNA that can contribute to its development or prevention.
Dr. Puyol also emphasized a desire to cure “more cancers,” but also to prevent their initial occurrence. This strategy, she explains, functions like a “biological antivirus” by acting at the root of the problem, intercepting cellular and molecular changes that could initiate the disease. The funding will allow researchers to dedicate “time, effort, and resources” to understanding and strengthening “prevention mechanisms.”
This initiative represents a paradigm shift, prioritizing prevention as a key strategy to reduce cancer incidence at its molecular origin.
Aiming for Over 70% Survival Rate by 2030
In Spain, one in two men and one in three women will be diagnosed with a malignant neoplasm during their lifetime. Currently, someone receives a cancer diagnosis every two minutes. Given the scale of this health challenge, boosting oncology research is a critical priority.
The Spanish Association for Cancer Research is working towards exceeding a 70% cancer survival rate by 2030. To achieve this, the organization is focused on increasing funding for research, maximizing impact by covering all phases of the disease – from prevention and diagnosis to the treatment of metastasis – and fostering a robust scientific environment.
